Lung cancer is closely linked to smoking, so why are so many Australians who have never lit up dying of it?

Original article by Katie Hampson
The West Australian – Page: Online : 15-Mar-23

About 80 per cent of people who develop lung cancer are smokers or ex-smokers. However, Melissa Treby from Cancer Council Western Australia says it is estimated that 16.1 per cent of lung cancer cases in men and 28.9 per cent in women that will be diagnosed in Australia between 2017 and 2026 will not be attributable to active smoking. She says other known risk factors include exposure to occupational carcinogens such as silica dust, asbestos and diesel engine exhaust. People may also be at heightened risk of lung cancer if they have a family history of the disease.

CORPORATES
CANCER COUNCIL WESTERN AUSTRALIA

Cancer drug gives hope but is still on the waiting list

Original article by Julia Medew
The Age – Page: 13 : 5-Dec-14

Some 300 Australians annually, or 5% of all who are suffering from lung cancer, can benefit substantially from Pfizer’s Crizotinib drug. It can boost the life expectancy of the patients, which is especially important as the non-small cell lung cancer variant tends to affect young people more. However the cost of the treatment is $A90,000 per year, and the Federal Government may not approve the drug for subsidies under the pharmaceutical benefits scheme in late 2014

CORPORATES
AUSTRALIA. PHARMACEUTICAL BENEFITS ADVISORY COMMITTEE, PFIZER PTY LTD, PETER MACCALLUM CANCER INSTITUTE